A Novel Digital Music-based Autonomous Personalized Walking Intervention to Improve Gait and Walking Automaticity in Parkinson Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorBoston University Charles River Campus

About this trial

The purpose of this research study is to examine the effects of a 3-month personalized community-based walking program called MyMusiQ. The study uses music cues delivered through a digital device in people with Parkinson disease (PD). The investigators want to know if personalized music cueing through the digital device can improve walking quality, walking ability, daily walking amount and intensity, and quality of life, while helping walking feel more automatic and require less mental effort. Participants will take part in this research study for approximately 18 weeks in total. During this time, participants will complete 4 study visits at designated research centers at Boston University, Washington University in St. Louis, or the University of Utah, depending on the site of enrollment.

Eligibility criteria

Qualifiers

Self-report of diagnosis of typical Parkinson disease determined by a medical doctor

≥ 40 years of age

Community-dwelling (e.g. home, independent living, senior housing)

Have stable PD medications for at least two weeks prior to enrollment

Disqualifiers

< 40 years of age

Diagnosis of atypical Parkinsonism

Modified Hoehn and Yahr stages 4-5

Significantly disturbing freezing episodes during daily walking based on the New Freezing of Gait Questionnaire (Part III Item 7)

Trial design

Treatments tested in this trial

  • MR-005 (MedRhythms, Inc., Portland, ME)

Treatment groups

200 Participants
are divided into 1 treatment group

Sponsors and collaborators

Boston University Charles River Campus

Lead sponsor

Michael J. Fox Foundation for Parkinson's Research

Collaborator

University of Utah

Collaborator

Washington University School of Medicine

Collaborator